Skocz do pozycji: 1.

Tytuł:

The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update.

Autorzy:

Jakubowska A; Borthwick Diabetes Research Centre, Lister Hospital, Stevenage, UK.
Roux CWL; Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland.
Viljoen A; Borthwick Diabetes Research Centre, Lister Hospital, Stevenage, UK.

Pokaż więcej

Źródło:

Endocrinology and metabolism (Seoul, Korea) [Endocrinol Metab (Seoul)] 2024 Feb; Vol. 39 (1), pp. 12-22. Date of Electronic Publication: 2024 Feb 14.

Typ publikacji:

Review; Journal Article

MeSH Terms:

Glucagon-Like Peptide 1*/pharmacology
Glucagon-Like Peptide 1*/therapeutic use
Diabetes Mellitus, Type 2*/drug therapy
Receptors, Gastrointestinal Hormone*
Humans ; Receptors, Glucagon/therapeutic use ; Gastric Inhibitory Polypeptide/pharmacology ; Gastric Inhibitory Polypeptide/physiology ; Gastric Inhibitory Polypeptide/therapeutic use ; Obesity/drug therapy ; Weight Loss ; Receptors, G-Protein-Coupled ; Glucose ; Randomized Controlled Trials as Topic ; Clinical Trials, Phase II as Topic

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 2.

Tytuł:

Secretion of glucagon, GLP-1 and GIP may be affected by circadian rhythm in healthy males.

Autorzy:

Zilstorff DB; Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg Hospital, Copenhagen, Denmark.
Richter MM; Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg Hospital, Copenhagen, Denmark.; NNF Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Hannibal J; Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Jørgensen HL; Department of Clinical Biochemistry, Copenhagen University Hospital - Hvidovre, Hvidovre, Denmark.
Sennels HP; Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg Hospital, Copenhagen, Denmark.
Wewer Albrechtsen NJ; Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg Hospital, Copenhagen, Denmark. .; NNF Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. .

Pokaż więcej

Źródło:

BMC endocrine disorders [BMC Endocr Disord] 2024 Mar 14; Vol. 24 (1), pp. 38. Date of Electronic Publication: 2024 Mar 14.

Typ publikacji:

Journal Article

MeSH Terms:

Glucagon*/metabolism
Glucagon-Like Peptide 1*
Male ; Humans ; Insulin ; C-Peptide ; Gastric Inhibitory Polypeptide ; Blood Glucose/metabolism ; Glucose/pharmacology ; Circadian Rhythm

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 3.

Tytuł:

Hot weight loss drugs tested against addiction.

Autorzy:

Leslie M

Pokaż więcej

Źródło:

Science (New York, N.Y.) [Science] 2023 Sep; Vol. 381 (6661), pp. 930-931. Date of Electronic Publication: 2023 Aug 31.

Typ publikacji:

Wiadomości

MeSH Terms:

Anti-Obesity Agents*/pharmacology
Anti-Obesity Agents*/therapeutic use
Behavior, Addictive*/drug therapy
Glucagon-Like Peptide 1*/analogs & derivatives
Glucagon-Like Peptide 1*/pharmacology
Glucagon-Like Peptide 1*/therapeutic use
Substance-Related Disorders*/drug therapy
Humans ; Alcoholism/drug therapy

Periodyk

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 4.

Tytuł:

Sidelined.

Autorzy:

Couzin-Frankel J

Pokaż więcej

Źródło:

Science (New York, N.Y.) [Science] 2023 Sep 22; Vol. 381 (6664), pp. 1274-1277. Date of Electronic Publication: 2023 Sep 21.

Typ publikacji:

Wiadomości

MeSH Terms:

Glucagon-Like Peptide 1*
Obesity*
Anti-Obesity Agents*
Scientific Misconduct*
Female ; Humans

Periodyk

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 5.

Tytuł:

A peptide triple agonist of GLP-1, neuropeptide Y1, and neuropeptide Y2 receptors promotes glycemic control and weight loss.

Autorzy:

Chichura KS; Department of Chemistry, Syracuse University, 111 College Place, Syracuse, NY, 13244, USA.
Elfers CT; Seattle Children's Research Institute, 1900 Ninth Ave, Seattle, WA, 98101, USA.
Salameh TS; Seattle Children's Research Institute, 1900 Ninth Ave, Seattle, WA, 98101, USA.
Kamat V; Diabetes Research Institute and Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA, 98195, USA.
Chepurny OG; Department of Medicine, State University of New York, Upstate Medical University, Syracuse, NY, 13210, USA.
McGivney A; Department of Chemistry, Syracuse University, 111 College Place, Syracuse, NY, 13244, USA.
Milliken BT; Department of Chemistry, Syracuse University, 111 College Place, Syracuse, NY, 13244, USA.
Holz GG; Department of Medicine, State University of New York, Upstate Medical University, Syracuse, NY, 13210, USA.; Department of Pharmacology, State University of New York, Upstate Medical University, Syracuse, NY, 13210, USA.
Applebey SV; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Hayes MR; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Sweet IR; Diabetes Research Institute and Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA, 98195, USA.
Roth CL; Seattle Children's Research Institute, 1900 Ninth Ave, Seattle, WA, 98101, USA. .; Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, 98105, USA. .
Doyle RP; Department of Chemistry, Syracuse University, 111 College Place, Syracuse, NY, 13244, USA. .; Department of Medicine, State University of New York, Upstate Medical University, Syracuse, NY, 13210, USA. .; Department of Pharmacology, State University of New York, Upstate Medical University, Syracuse, NY, 13210, USA. .

Pokaż więcej

Źródło:

Scientific reports [Sci Rep] 2023 Jun 12; Vol. 13 (1), pp. 9554. Date of Electronic Publication: 2023 Jun 12.

Typ publikacji:

Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't

MeSH Terms:

Glucagon-Like Peptide 1*
Neuropeptides*
Humans ; Animals ; Rats ; Glycemic Control ; Weight Loss ; Peptide YY

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 6.

Tytuł:

Glucagon-like peptide-1 facilitates cerebellar parallel fiber glutamate release through PKA signaling in mice in vitro.

Autorzy:

Wang XY; Department of Neurology, Affiliated Hospital of Yanbian University, Yanji, 133000, Jilin, China.
Liu Y; Department of Physiology, College of Basic Medicine, Jilin Medical University, Jilin, 132013, Jilin, China.
Cao LX; Department of Physiology and Pathophysiology, College of Medicine, Yanbian University, Yanji, 133000, Jilin, China.
Li YZ; Department of Cardiology, Affiliated Hospital of Yanbian University, Yanji, 133000, Jilin, China.
Wan P; Department of Physiology, College of Basic Medicine, Jilin Medical University, Jilin, 132013, Jilin, China. Wpeng_.
Qiu DL; Department of Physiology, College of Basic Medicine, Jilin Medical University, Jilin, 132013, Jilin, China. dlqiu_.

Pokaż więcej

Źródło:

Scientific reports [Sci Rep] 2023 May 16; Vol. 13 (1), pp. 7948. Date of Electronic Publication: 2023 May 16.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Glutamic Acid*/pharmacology
Glucagon-Like Peptide 1*/pharmacology
Mice ; Animals ; Glucagon-Like Peptide-1 Receptor ; Cerebellum/physiology ; Purkinje Cells/physiology ; Synaptic Transmission/physiology

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 7.

Tytuł:

Relationship of Glucagon-like Peptide 1 and Peptide YY with Catch-up Growth in Children Born Small for Gestational Age

Autorzy:

Wang L; National Center for Children’s Health, Capital Medical University, Beijing Children’s Hospital, Clinic of Endocrinology, Beijing, China; Shenzhen Children’s Hospital, Clinic of Endocrinology, Shenzhen, China
Su Z; Shenzhen Children’s Hospital, Clinic of Endocrinology, Shenzhen, China
Li YC; National Center for Children’s Health, Capital Medical University, Beijing Children’s Hospital, Clinic of Endocrinology, Beijing, China
Cao BY; National Center for Children’s Health, Capital Medical University, Beijing Children’s Hospital, Clinic of Endocrinology, Beijing, China
Su C; National Center for Children’s Health, Capital Medical University, Beijing Children’s Hospital, Clinic of Endocrinology, Beijing, China
Gong CX; National Center for Children’s Health, Capital Medical University, Beijing Children’s Hospital, Clinic of Endocrinology, Beijing, China

Pokaż więcej

Źródło:

Journal of clinical research in pediatric endocrinology [J Clin Res Pediatr Endocrinol] 2024 Mar 11; Vol. 16 (1), pp. 69-75. Date of Electronic Publication: 2023 Oct 17.

Typ publikacji:

Journal Article

MeSH Terms:

Diabetes Mellitus, Type 2*
Insulin Resistance*
Child ; Infant, Newborn ; Humans ; Peptide YY ; Gestational Age ; Infant, Small for Gestational Age ; Insulin ; Glucose ; Glucagon-Like Peptide 1

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 8.

Tytuł:

Obesity Treatments to Improve Type 1 Diabetes (OTID): a randomized controlled trial of the combination of glucagon-like peptide 1 analogues and sodium-glucose cotransporter 2 inhibitors-protocol for Obesity Treatments to Improve Type 1 Diabetes (the OTID trial).

Autorzy:

Al-Ozairi E; Dasman Diabetes Institute, Kuwait City, Kuwait.
Narula K; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK. .
Miras AD; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.; School of Medicine, Ulster University, Coleraine, UK.
Taghadom E; Dasman Diabetes Institute, Kuwait City, Kuwait.; Amiri Hospital, Ministry of Health, Kuwait City, Kuwait.
Samad AE; Dasman Diabetes Institute, Kuwait City, Kuwait.
Al Kandari J; Dasman Diabetes Institute, Kuwait City, Kuwait.; Amiri Hospital, Ministry of Health, Kuwait City, Kuwait.
Alyosef A; Amiri Hospital, Ministry of Health, Kuwait City, Kuwait.
Mashankar A; Dasman Diabetes Institute, Kuwait City, Kuwait.
Al-Najim W; School of Medicine, Ulster University, Coleraine, UK.; Diabetes Complications Research Centre, Conway Institute, University College of Dublin, Dublin, Ireland.
le Roux CW; School of Medicine, Ulster University, Coleraine, UK.; Diabetes Complications Research Centre, Conway Institute, University College of Dublin, Dublin, Ireland.

Pokaż więcej

Źródło:

Trials [Trials] 2024 Feb 16; Vol. 25 (1), pp. 129. Date of Electronic Publication: 2024 Feb 16.

Typ publikacji:

Clinical Trial Protocol; Journal Article

MeSH Terms:

Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 1*/diagnosis
Diabetes Mellitus, Type 1*/drug therapy
Diabetes Mellitus, Type 1*/complications
Sodium-Glucose Transporter 2 Inhibitors*/adverse effects
Renal Insufficiency, Chronic*/diagnosis
Renal Insufficiency, Chronic*/drug therapy
Renal Insufficiency, Chronic*/complications
Humans ; Young Adult ; Adult ; Middle Aged ; Aged ; Hypoglycemic Agents/adverse effects ; Glucagon-Like Peptide 1 ; Obesity/complications ; Obesity/diagnosis ; Obesity/drug therapy ; Glucose ; Sodium ; Randomized Controlled Trials as Topic

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 9.

Tytuł:

Special Issue: "Anti-inflammatory Effects of Glucagon-like Peptide-1".

Autorzy:

Puddu A; Department of Internal Medicine and Medical Specialties, University of Genoa, 16132 Genoa, Italy.
Maggi D; Department of Internal Medicine and Medical Specialties, University of Genoa, 16132 Genoa, Italy.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2024 Feb 07; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 07.

Typ publikacji:

Editorial

MeSH Terms:

Diabetes Mellitus, Type 2*/drug therapy
Cardiovascular System*
Humans ; Glucagon-Like Peptide 1/pharmacology ; Glucagon-Like Peptide 1/therapeutic use ; Heart ; Anti-Inflammatory Agents/pharmacology ; Anti-Inflammatory Agents/therapeutic use ; Glucagon-Like Peptide-1 Receptor ; Hypoglycemic Agents/pharmacology

Opinia redakcyjna

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 10.

Tytuł:

Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature.

Autorzy:

Chrysavgis, Lampros G. (AUTHOR)
Kazanas, Spyridon (AUTHOR)
Bafa, Konstantina (AUTHOR)
Rozani, Sophia (AUTHOR)
Koloutsou, Maria-Evangelia (AUTHOR)
Cholongitas, Evangelos (AUTHOR)

Pokaż więcej

Źródło:

International Journal of Molecular Sciences. Apr2024, Vol. 25 Issue 7, p3832. 28p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 11.

Tytuł:

Effect of Food Consumption on the Pharmacokinetics, Safety, and Tolerability of Once-Daily Orally Administered Orforglipron (LY3502970), a Non-peptide GLP-1 Receptor Agonist.

Autorzy:

Ma, Xiaosu (AUTHOR)
Liu, Rong (AUTHOR)
Pratt, Edward J. (AUTHOR)
Benson, Charles T. (AUTHOR)
Bhattachar, Shobha N. (AUTHOR)
Sloop, Kyle W. (AUTHOR)

Pokaż więcej

Źródło:

Diabetes Therapy. Apr2024, Vol. 15 Issue 4, p819-832. 14p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 12.

Tytuł:

Impact of Glucagon-Like Peptide 1 Agonist Deprescription in Type 2 Diabetes in a Real-World Setting: A Propensity Score Matched Cohort Study.

Autorzy:

McKenzie, Amy L. (AUTHOR)
Athinarayanan, Shaminie J. (AUTHOR)

Pokaż więcej

Źródło:

Diabetes Therapy. Apr2024, Vol. 15 Issue 4, p843-853. 11p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 13.

Tytuł:

Recent Advances in the Management of Diabetic Kidney Disease: Slowing Progression.

Autorzy:

Wang, Na (AUTHOR)
Zhang, Chun (AUTHOR)

Pokaż więcej

Źródło:

International Journal of Molecular Sciences. Mar2024, Vol. 25 Issue 6, p3086. 33p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 14.

Tytuł:

Timosaponin A3 Induces Anti-Obesity and Anti-Diabetic Effects In Vitro and In Vivo.

Autorzy:

Park, Ji-Hyuk (AUTHOR)
Jee, Wona (AUTHOR)
Park, So-Mi (AUTHOR)
Park, Ye-Rin (AUTHOR)
Kim, Seok Woo (AUTHOR)
Bae, Hanbit (AUTHOR)
Chung, Won-Suk (AUTHOR)
Cho, Jae-Heung (AUTHOR)
Kim, Hyungsuk (AUTHOR)
Song, Mi-Yeon (AUTHOR)
Jang, Hyeung-Jin (AUTHOR)

Pokaż więcej

Źródło:

International Journal of Molecular Sciences. Mar2024, Vol. 25 Issue 5, p2914. 16p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 15.

Tytuł:

Is Tirzepatide the New Game Changer in Type 2 Diabetes?

Autorzy:

Lisco, Giuseppe (AUTHOR)
Disoteo, Olga Eugenia (AUTHOR)
De Geronimo, Vincenzo (AUTHOR)
De Tullio, Anna (AUTHOR)
Giagulli, Vito Angelo (AUTHOR)
Guastamacchia, Edoardo (AUTHOR)
De Pergola, Giovanni (AUTHOR)
Jirillo, Emilio (AUTHOR)
Triggiani, Vincenzo (AUTHOR)

Pokaż więcej

Źródło:

Endocrines. Mar2024, Vol. 5 Issue 1, p72-86. 15p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 16.

Tytuł:

Impact of Glucagon-Like Peptide 1 Receptor Agonists on Biochemical Markers of the Initiation of Atherosclerotic Process.

Autorzy:

Hachuła, Marcin (AUTHOR)
Kosowski, Michał (AUTHOR)
Ryl, Sabina (AUTHOR)
Basiak, Marcin (AUTHOR)
Okopień, Bogusław (AUTHOR)

Pokaż więcej

Źródło:

International Journal of Molecular Sciences. Feb2024, Vol. 25 Issue 3, p1854. 12p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 17.

Tytuł:

An LC-MS/MS Method for the Simultaneous Quantification of Insulin, Cortisol, Glucagon-like Peptide 1, Ghrelin, and Osteocalcin.

Autorzy:

Zhang, Zhichao (AUTHOR)
Siddiqi, Hareem (AUTHOR)
Huang, Yu-Ping (AUTHOR)
McClorry, Shannon (AUTHOR)
Ji, Peng (AUTHOR)
Barile, Daniela (AUTHOR)
Slupsky, Carolyn M. (AUTHOR)

Pokaż więcej

Źródło:

Separations (2297-8739). Feb2024, Vol. 11 Issue 2, p41. 12p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 18.

Tytuł:

Semaglutide Modulates Extracellular Matrix Production of LX-2 Cells via Exosomes and Improves Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Autorzy:

Scavo, Maria Principia (AUTHOR)
Lisco, Giuseppe (AUTHOR)
Depalo, Nicoletta (AUTHOR)
Rizzi, Federica (AUTHOR)
Volpe, Sara (AUTHOR)
Arrè, Valentina (AUTHOR)
Carrieri, Livianna (AUTHOR)
Notarnicola, Maria (AUTHOR)
De Nunzio, Valentina (AUTHOR)
Curri, Maria Lucia (AUTHOR)
De Pergola, Giovanni (AUTHOR)
Piazzolla, Giuseppina (AUTHOR)
Giannelli, Gianluigi (AUTHOR)

Pokaż więcej

Źródło:

International Journal of Molecular Sciences. Feb2024, Vol. 25 Issue 3, p1493. 18p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 19.

Tytuł:

Isosinensetin Stimulates Glucagon-like Peptide-1 Secretion via Activation of hTAS2R50 and the G βγ -Mediated Signaling Pathway.

Autorzy:

Lee SH; College of Korean Medicine, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea.; Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
Ko HM; College of Korean Medicine, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea.; Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
Jee W; College of Korean Medicine, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea.; Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
Kim H; College of Korean Medicine, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea.
Chung WS; College of Korean Medicine, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea.
Jang HJ; College of Korean Medicine, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea.; Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2023 Feb 12; Vol. 24 (4). Date of Electronic Publication: 2023 Feb 12.

Typ publikacji:

Journal Article

MeSH Terms:

Glucagon-Like Peptide 1*/drug effects
Glucagon-Like Peptide 1*/metabolism
Receptors, G-Protein-Coupled*/metabolism
Signal Transduction*
Humans ; Enteroendocrine Cells/metabolism ; Gastrointestinal Tract/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 20.

Tytuł:

Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Intima-Media Thickness: Systematic Review and Meta-Analysis.

Autorzy:

Akbari A; Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.; Research Center for Advanced Technologies in Cardiovascular Medicine, Cardiovascular Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Hadizadeh S; Research Center for Advanced Technologies in Cardiovascular Medicine, Cardiovascular Research Institute, Tehran University of Medical Sciences, Tehran, Iran.; Women Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Heidary L; Laboratory of Medical Genetics, ART and Stem Cell Research Centre (ACECR), Tabriz, Iran.; Nahal Infertility Center, Tabriz, Iran.

Pokaż więcej

Źródło:

Journal of diabetes research [J Diabetes Res] 2024 Mar 18; Vol. 2024, pp. 3212795. Date of Electronic Publication: 2024 Mar 18 (Print Publication: 2024).

Typ publikacji:

Meta-Analysis; Systematic Review; Journal Article; Review

MeSH Terms:

Carotid Intima-Media Thickness*
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Glucagon-Like Peptide-1 Receptor Agonists*/therapeutic use
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Humans ; Glucagon-Like Peptide 1/therapeutic use ; Glucagon-Like Peptide-1 Receptor/agonists ; Hypoglycemic Agents/pharmacology ; Hypoglycemic Agents/therapeutic use ; Cardiovascular Diseases/drug therapy ; Cardiovascular Diseases/prevention & control

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 21.

Tytuł:

SGLT2 Inhibitors and GLP-1 Agonists: A Beacon of Hope for Stroke Prevention in Diabetes.

Autorzy:

Jeon JH; Department of Internal Medicine, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, Korea.

Pokaż więcej

Źródło:

Diabetes & metabolism journal [Diabetes Metab J] 2024 Mar; Vol. 48 (2), pp. 213-214. Date of Electronic Publication: 2024 Mar 22.

Typ publikacji:

Editorial

MeSH Terms:

Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Stroke*/etiology
Stroke*/prevention & control
Humans ; Hypoglycemic Agents/therapeutic use ; Hypoglycemic Agents/pharmacology ; Glucagon-Like Peptide 1

Opinia redakcyjna

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 22.

Tytuł:

Comparative Effect of Glucose-Lowering Drugs for Type 2 Diabetes Mellitus on Stroke Prevention: A Systematic Review and Network Meta-Analysis.

Autorzy:

Kim JS; International Healthcare Center, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea.
Lee G; Esther Formula Medical Food R&D Center, Seoul, Korea.
Park KI; Department of Neurology, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea.
Oh SW; Department of Family Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul National University College of Medicine, Seoul, Korea.

Pokaż więcej

Źródło:

Diabetes & metabolism journal [Diabetes Metab J] 2024 Mar; Vol. 48 (2), pp. 312-320. Date of Electronic Publication: 2024 Jan 26.

Typ publikacji:

Meta-Analysis; Systematic Review; Journal Article

MeSH Terms:

Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/chemically induced
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Humans ; Hypoglycemic Agents/adverse effects ; Network Meta-Analysis ; Glucose ; Glycated Hemoglobin ; Glucagon-Like Peptide 1

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 23.

Tytuł:

Exploring FDA-Approved Frontiers: Insights into Natural and Engineered Peptide Analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and α-MSH Realms.

Autorzy:

Al Musaimi O; School of Pharmacy, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.; Department of Chemical Engineering, Imperial College London, London SW7 2AZ, UK.

Pokaż więcej

Źródło:

Biomolecules [Biomolecules] 2024 Feb 22; Vol. 14 (3). Date of Electronic Publication: 2024 Feb 22.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Adrenocorticotropic Hormone*
alpha-MSH*/pharmacology
United States ; Cholecystokinin ; Glucagon-Like Peptide 1 ; United States Food and Drug Administration ; Melanocyte-Stimulating Hormones ; Transcription Factors

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 24.

Tytuł:

Infertility Improvement after Medical Weight Loss in Women and Men: A Review of the Literature.

Autorzy:

Pavli P; 2nd Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, 'Aretaieion' University Hospital, 11528 Athens, Greece.
Triantafyllidou O; 2nd Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, 'Aretaieion' University Hospital, 11528 Athens, Greece.
Kapantais E; Department of Diabetes and Obesity, Metropolitan Hospital, 18547 Athens, Greece.
Vlahos NF; 2nd Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, 'Aretaieion' University Hospital, 11528 Athens, Greece.
Valsamakis G; 2nd Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, 'Aretaieion' University Hospital, 11528 Athens, Greece.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2024 Feb 05; Vol. 25 (3). Date of Electronic Publication: 2024 Feb 05.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Infertility, Female*/therapy
Pregnancy ; Humans ; Male ; Female ; Sperm Motility ; Reproduction ; Weight Loss ; Glucagon-Like Peptide 1

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 25.

Tytuł:

Circulating glucagon-like peptide-1 level in patients with liver cirrhosis.

Autorzy:

Nouri-Vaskeh M; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Khalili N; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Khalaji A; Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Behnam P; Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Alizadeh L; Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Ebrahimi S; Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Gilani N; Department of Statistics and Epidemiology, Faculty of Health, Tabriz University of Medical Sciences, Tabriz, Iran.
Mohammadi M; Department of Biological Science, University of Calgary, Calgary, Canada.; Center for Bioengineering Research and Education, University of Calgary, Calgary, Canada.
Madinehzadeh SA; Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Zarei M; Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Pokaż więcej

Źródło:

Archives of physiology and biochemistry [Arch Physiol Biochem] 2023 Apr; Vol. 129 (2), pp. 373-378. Date of Electronic Publication: 2020 Oct 12.

Typ publikacji:

Journal Article

MeSH Terms:

Glucagon-Like Peptide 1*
Liver Diseases*
Humans ; Adult ; Middle Aged ; Incretins ; Cross-Sectional Studies ; Liver Cirrhosis/diagnosis ; Severity of Illness Index ; Prognosis

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 26.

Tytuł:

Low soluble dipeptidyl Peptidase-4 levels during acute myocardial infarction and decreased endogenous glucagon like Peptide-1 response are associated with adverse long-term cardiovascular outcome and mortality: A pilot study.

Autorzy:

Mengesha B; Department of Cardiology, Shamir Medical Center, Be'er Yaakov, Israel.; Affiliated with Sackler School of Medicine, Tel-Aviv University, Ramat-Aviv, Israel.
Blatt A; Cardiology Center, Kaplan Medical Center, Affiliated with Hebrew University of Jerusalem, Jerusalem, Israel.
Bloch O; Affiliated with Sackler School of Medicine, Tel-Aviv University, Ramat-Aviv, Israel.; Immunology and Diabetes research laboratory, Shamir medical Center, Be'er Ya'akov, Israel.
Rapoport MJ; Affiliated with Sackler School of Medicine, Tel-Aviv University, Ramat-Aviv, Israel.; Immunology and Diabetes research laboratory, Shamir medical Center, Be'er Ya'akov, Israel.; Department of Internal Medicine 'C', Shamir Medical Center, Be'er Ya'akov, Israel.

Pokaż więcej

Źródło:

European journal of clinical investigation [Eur J Clin Invest] 2023 Mar; Vol. 53 (3), pp. e13897. Date of Electronic Publication: 2022 Nov 28.

Typ publikacji:

Journal Article

MeSH Terms:

Glucagon-Like Peptide 1*
Myocardial Infarction*
Humans ; Pilot Projects ; Heart ; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases ; Dipeptidyl Peptidase 4

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 27.

Tytuł:

Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 secretion in humans: Characteristics and regulation.

Autorzy:

Alsalim W; Department of Clinical Sciences Lund, Lund University, Lund, Sweden.; Department of Endocrinology, Skåne University Hospital, Lund, Sweden.
Lindgren O; Department of Clinical Sciences Lund, Lund University, Lund, Sweden.; Department of Endocrinology, Skåne University Hospital, Lund, Sweden.
Ahrén B; Department of Clinical Sciences Lund, Lund University, Lund, Sweden.; Department of Endocrinology, Skåne University Hospital, Lund, Sweden.

Pokaż więcej

Źródło:

Journal of diabetes investigation [J Diabetes Investig] 2023 Mar; Vol. 14 (3), pp. 354-361. Date of Electronic Publication: 2022 Dec 20.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Glucagon-Like Peptide 1*
Incretins*
Humans ; Blood Glucose ; Insulin ; Glucose ; Gastric Inhibitory Polypeptide ; Peptide Fragments

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 28.

Tytuł:

Intraperitoneal administration of nesfatin‑1 stimulates glucagon‑like peptide‑1 secretion in fasted mice.

Autorzy:

Tagawa N; Laboratory of Medical Biochemistry, Kobe Pharmaceutical University, Kobe, Hyogo 685‑8558, Japan.
Ogura H; Laboratory of Medical Biochemistry, Kobe Pharmaceutical University, Kobe, Hyogo 685‑8558, Japan.
Miyawaki H; Laboratory of Medical Biochemistry, Kobe Pharmaceutical University, Kobe, Hyogo 685‑8558, Japan.
Asakawa A; Department of Psychosomatic Internal Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima 890‑8544, Japan.
Kato I; Laboratory of Medical Biochemistry, Kobe Pharmaceutical University, Kobe, Hyogo 685‑8558, Japan.

Pokaż więcej

Źródło:

Molecular medicine reports [Mol Med Rep] 2023 Jan; Vol. 27 (1). Date of Electronic Publication: 2022 Nov 11.

Typ publikacji:

Journal Article

MeSH Terms:

Glucagon-Like Peptide 1*
Diabetes Mellitus, Type 2*/metabolism
Mice ; Rats ; Animals ; Enteroendocrine Cells ; Insulin/metabolism ; Glucose/metabolism ; Blood Glucose/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 29.

Tytuł:

Effect of fasting on short-term visual plasticity in adult humans.

Autorzy:

Animali S; Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.
Steinwurzel C; Department of Neuroscience, Psychology, Pharmacology and Child Health, University of Florence, Florence, Italy.; Department of Translational Research on New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Dardano A; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Sancho-Bornez V; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Del Prato S; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Morrone MC; Department of Translational Research on New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; IRCCS Stella Maris Foundation, Pisa, Italy.
Daniele G; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Binda P; Department of Translational Research on New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Pokaż więcej

Źródło:

The European journal of neuroscience [Eur J Neurosci] 2023 Jan; Vol. 57 (1), pp. 148-162. Date of Electronic Publication: 2022 Dec 09.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Glucagon-Like Peptide 1*
Glucose*/metabolism
Humans ; Adult ; Obesity ; Fasting ; Insulin

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 30.

Tytuł:

Tirzepatide prevents neurodegeneration through multiple molecular pathways.

Autorzy:

Fontanella, Rosaria Anna (AUTHOR)
Ghosh, Puja (AUTHOR)
Pesapane, Ada (AUTHOR)
Taktaz, Fatemeh (AUTHOR)
Puocci, Armando (AUTHOR)
Franzese, Martina (AUTHOR)
Feliciano, Maria Federica (AUTHOR)
Tortorella, Giovanni (AUTHOR)
Scisciola, Lucia (AUTHOR)
Sommella, Eduardo (AUTHOR)
Ambrosino, Concetta (AUTHOR)
Paolisso, Giuseppe (AUTHOR)
Barbieri, Michelangela (AUTHOR)

Pokaż więcej

Źródło:

Journal of Translational Medicine. 1/30/2024, Vol. 22 Issue 1, p1-15. 15p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 31.

Tytuł:

Effects of finerenone and glucagon-like peptide 1 receptor agonists on cardiovascular and renal outcomes in type 2 diabetes mellitus: a systematic review and meta-analysis.

Autorzy:

Gu, Xia (AUTHOR)
Jiang, Shimin (AUTHOR)
Yang, Yue (AUTHOR)
Li, Wenge (AUTHOR)

Pokaż więcej

Źródło:

Diabetology & Metabolic Syndrome. 1/11/2024, Vol. 16, p1-12. 12p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 32.

Tytuł:

High frequency of germline recombination in Nestin-Cre transgenic mice crossed with Glucagon-like peptide 1 receptor floxed mice.

Autorzy:

Kajitani, Yusuke (AUTHOR)
Miyazawa, Takashi (AUTHOR)
Inoue, Tomoaki (AUTHOR)
Kajitani, Nao (AUTHOR)
Fujita, Masamichi (AUTHOR)
Takeichi, Yukina (AUTHOR)
Miyachi, Yasutaka (AUTHOR)
Sakamoto, Ryuichi (AUTHOR)
Ogawa, Yoshihiro (AUTHOR)

Pokaż więcej

Źródło:

PLoS ONE. 12/20/2023, Vol. 18 Issue 12, p1-17. 17p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 33.

Tytuł:

GLP1R rs3765467 Polymorphism Is Associated with the Risk of Early Onset Type 2 Diabetes.

Autorzy:

Fang, Yunyun (AUTHOR)
Zhang, Jingjing (AUTHOR)
Ji, Linlin (AUTHOR)
Zhu, Chaoyu (AUTHOR)
Xiao, Yuanyuan (AUTHOR)
Gao, Qingge (AUTHOR)
Song, Wenjing (AUTHOR)
Wei, Li (AUTHOR)

Pokaż więcej

Źródło:

International Journal of Endocrinology. 12/14/2023, p1-9. 9p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 34.

Tytuł:

New perspectives on the use of glucagon-like peptide 1 in diseases of the central nervous system.

Autorzy:

Lupina, Malgorzata (AUTHOR)
Listos, Joanna (AUTHOR)

Pokaż więcej

Źródło:

Current Issues in Pharmacy & Medical Sciences. Dec2023, Vol. 36 Issue 4, p232-235. 4p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 35.

Tytuł:

Relationship between lipid profile, anthropometric indicators, and appetite-regulating hormones in infants according to type of feeding.

Autorzy:

Vásquez-Garibay, Edgar M.
Larrosa-Haro, Alfredo
Muñoz-Esparza, Nelly
Romero-Velarde, Enrique
Guzmán-Mercado, Elizabeth
García-Arellano, Samuel
Martínez-Limón, Felipe
Francisco Muñoz-Valle, José

Pokaż więcej

Alternatywny tytuł:

Relación entre perfil lipídico, indicadores antropométricos y hormonas reguladoras del apetito en lactantes según tipo de alimentación.

Źródło:

Nutrición Hospitalaria. nov/dic2023, Vol. 40 Issue 6, p1152-1158. 7p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 36.

Tytuł:

Patient-Reported Outcomes in People with Type 2 Diabetes Receiving Tirzepatide in the SURPASS Clinical Trial Programme.

Autorzy:

Boye, Kristina S. (AUTHOR)
Thieu, Vivian Thuyanh (AUTHOR)
Sapin, Hélène (AUTHOR)
Lee, Clare J. (AUTHOR)
Landó, Laura Fernández (AUTHOR)
Brown, Katelyn (AUTHOR)
Bray, Ross (AUTHOR)
Wiese, Russell J. (AUTHOR)
Patel, Hiren (AUTHOR)
Rodríguez, Ángel (AUTHOR)
Yu, Maria (AUTHOR)

Pokaż więcej

Źródło:

Diabetes Therapy. Nov2023, Vol. 14 Issue 11, p1833-1852. 20p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 37.

Tytuł:

Evidence for Involvement of GIP and GLP-1 Receptors and the Gut-Gonadal Axis in Regulating Female Reproductive Function in Mice.

Autorzy:

Khan D; Biomedical Sciences Research Institute, School of Biomedical Sciences, Ulster University, Coleraine BT52 1SA, Northern Ireland, UK.
Ojo OO; Biomedical Sciences Research Institute, School of Biomedical Sciences, Ulster University, Coleraine BT52 1SA, Northern Ireland, UK.; Department of Biology, Chemistry & Forensic Science, School of Sciences, University of Wolverhampton, Wolverhampton WV1 1LY, UK.
Woodward OR; Metabolic Research Laboratories, Wellcome Trust MRC Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Hills Road, Cambridge CB2 0QQ, UK.
Lewis JE; Metabolic Research Laboratories, Wellcome Trust MRC Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Hills Road, Cambridge CB2 0QQ, UK.
Sridhar A; Biomedical Sciences Research Institute, School of Biomedical Sciences, Ulster University, Coleraine BT52 1SA, Northern Ireland, UK.
Gribble FM; Metabolic Research Laboratories, Wellcome Trust MRC Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Hills Road, Cambridge CB2 0QQ, UK.
Reimann F; Metabolic Research Laboratories, Wellcome Trust MRC Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Hills Road, Cambridge CB2 0QQ, UK.
Flatt PR; Biomedical Sciences Research Institute, School of Biomedical Sciences, Ulster University, Coleraine BT52 1SA, Northern Ireland, UK.
Moffett RC; Biomedical Sciences Research Institute, School of Biomedical Sciences, Ulster University, Coleraine BT52 1SA, Northern Ireland, UK.

Pokaż więcej

Źródło:

Biomolecules [Biomolecules] 2022 Nov 23; Vol. 12 (12). Date of Electronic Publication: 2022 Nov 23.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Gastric Inhibitory Polypeptide*/metabolism
Gastric Inhibitory Polypeptide*/pharmacology
Glucagon-Like Peptide 1*/metabolism
Glucagon-Like Peptide-1 Receptor*/genetics
Glucagon-Like Peptide-1 Receptor*/metabolism
Incretins*
Pregnancy Outcome*
Fertility*/genetics
Animals ; Female ; Male ; Mice ; Pregnancy ; Reproduction/genetics

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 38.

Tytuł:

Tirzepatide: A Systematic Update.

Autorzy:

Forzano I; Department of Advanced Biomedical Sciences, Division of Cardiology, 'Federico II' University, 80131 Naples, Italy.
Varzideh F; Department of Medicine, Division of Cardiology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Aging Research, Albert Einstein College of Medicine, New York, NY 10461, USA.; Department of Molecular Pharmacology, Einstein Institute for Neuroimmunology and Inflammation (INI), Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Fleischer Institute for Diabetes and Metabolism (FIDAM), Albert Einstein College of Medicine, New York, NY 10461, USA.
Avvisato R; Department of Advanced Biomedical Sciences, Division of Cardiology, 'Federico II' University, 80131 Naples, Italy.; Department of Medicine, Division of Cardiology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Aging Research, Albert Einstein College of Medicine, New York, NY 10461, USA.; Department of Molecular Pharmacology, Einstein Institute for Neuroimmunology and Inflammation (INI), Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Fleischer Institute for Diabetes and Metabolism (FIDAM), Albert Einstein College of Medicine, New York, NY 10461, USA.
Jankauskas SS; Department of Medicine, Division of Cardiology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Aging Research, Albert Einstein College of Medicine, New York, NY 10461, USA.; Department of Molecular Pharmacology, Einstein Institute for Neuroimmunology and Inflammation (INI), Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Fleischer Institute for Diabetes and Metabolism (FIDAM), Albert Einstein College of Medicine, New York, NY 10461, USA.
Mone P; Department of Medicine, Division of Cardiology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Aging Research, Albert Einstein College of Medicine, New York, NY 10461, USA.; Department of Molecular Pharmacology, Einstein Institute for Neuroimmunology and Inflammation (INI), Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Fleischer Institute for Diabetes and Metabolism (FIDAM), Albert Einstein College of Medicine, New York, NY 10461, USA.
Santulli G; Department of Advanced Biomedical Sciences, Division of Cardiology, 'Federico II' University, 80131 Naples, Italy.; Department of Medicine, Division of Cardiology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Aging Research, Albert Einstein College of Medicine, New York, NY 10461, USA.; Department of Molecular Pharmacology, Einstein Institute for Neuroimmunology and Inflammation (INI), Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Fleischer Institute for Diabetes and Metabolism (FIDAM), Albert Einstein College of Medicine, New York, NY 10461, USA.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2022 Nov 23; Vol. 23 (23). Date of Electronic Publication: 2022 Nov 23.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Glucagon-Like Peptide 1*/metabolism
Diabetes Mellitus, Type 2*/metabolism
Humans ; Gastric Inhibitory Polypeptide/therapeutic use ; Gastric Inhibitory Polypeptide/metabolism ; Incretins/therapeutic use ; Glucagon-Like Peptide-1 Receptor ; Glucose/therapeutic use ; Hypoglycemic Agents/pharmacology ; Hypoglycemic Agents/therapeutic use

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 39.

Tytuł:

Potential Roles of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) in Nondiabetic Populations.

Autorzy:

Xu D; CCRE, Curtin School of Population Health, Faculty of Health Sciences, Curtin University, Australia.; Curtin Medical School, Faculty of Health Sciences, Curtin University, Australia.; Department of Medical Education, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Nair A; Curtin Medical School, Faculty of Health Sciences, Curtin University, Australia.
Sigston C; St John of God Midland Public and Private Hospitals, 1 Clayton St, Midland, WA 6056, Australia.
Ho C; CCRE, Curtin School of Population Health, Faculty of Health Sciences, Curtin University, Australia.
Li J; Department of Pharmacy, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Yang D; Department of Medical Education, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Department of Cardiology, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Liao X; Department of Medical Education, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Department of Cardiology, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Chen W; Department of Medical Education, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Department of Renal Medicine, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Kuang M; Department of Medical Education, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Department of Surgery, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Li Y; Department of Medical Education, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Department of Endocrinology, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Reid C; CCRE, Curtin School of Population Health, Faculty of Health Sciences, Curtin University, Australia.
Xiao H; Department of Medical Education, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Department of Endocrinology, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.

Pokaż więcej

Źródło:

Cardiovascular therapeutics [Cardiovasc Ther] 2022 Nov 16; Vol. 2022, pp. 6820377. Date of Electronic Publication: 2022 Nov 16 (Print Publication: 2022).

Typ publikacji:

Journal Article; Review

MeSH Terms:

Glucagon-Like Peptide 1*
Diabetes Mellitus*
Humans

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 40.

Tytuł:

Nutrient Combinations Sensed by L-Cell Receptors Potentiate GLP-1 Secretion.

Autorzy:

Sodum N; Research Unit of Biomedicine and Internal Medicine, Biocentre of Oulu, Medical Research Center, University of Oulu, Oulu University Hospital, Aapistie 5, 90220 Oulu, Finland.
Mattila O; Research Unit of Biomedicine and Internal Medicine, Biocentre of Oulu, Medical Research Center, University of Oulu, Oulu University Hospital, Aapistie 5, 90220 Oulu, Finland.
Sharma R; Research Unit of Biomedicine and Internal Medicine, Biocentre of Oulu, Medical Research Center, University of Oulu, Oulu University Hospital, Aapistie 5, 90220 Oulu, Finland.
Kamakura R; Research Unit of Biomedicine and Internal Medicine, Biocentre of Oulu, Medical Research Center, University of Oulu, Oulu University Hospital, Aapistie 5, 90220 Oulu, Finland.
Lehto VP; Department of Technical Physics, Faculty of Science, Forestry and Technology, University of Eastern Finland, 70210 Kuopio, Finland.
Walkowiak J; Department of Gastroenterology and Metabolism, Poznan University of Medical Sciences, 60572 Poznań, Poland.
Herzig KH; Research Unit of Biomedicine and Internal Medicine, Biocentre of Oulu, Medical Research Center, University of Oulu, Oulu University Hospital, Aapistie 5, 90220 Oulu, Finland.; Department of Gastroenterology and Metabolism, Poznan University of Medical Sciences, 60572 Poznań, Poland.
Raza GS; Research Unit of Biomedicine and Internal Medicine, Biocentre of Oulu, Medical Research Center, University of Oulu, Oulu University Hospital, Aapistie 5, 90220 Oulu, Finland.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2024 Jan 16; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 16.

Typ publikacji:

Journal Article

MeSH Terms:

Amino Acids*
Dipeptidyl-Peptidase IV Inhibitors*
Humans ; Animals ; Mice ; L Cells ; Tryptophan ; Antiviral Agents ; Glucagon-Like Peptide 1/pharmacology ; Hypoglycemic Agents ; Nutrients ; Obesity

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 41.

Tytuł:

Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes.

Autorzy:

Yen FS; Dr. Yen's Clinic, No. 15, Shanying Road, Gueishan District, Taoyuan, Taiwan.
Hou MC; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Institute of Clinical Medicine, School of Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan.
Wei JC; Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.
Shih YH; Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan.; College of Medicine, China Medical University, Taichung City, Taiwan.
Hwu CM; Institute of Clinical Medicine, School of Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan. .; Section of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. .
Hsu CC; Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Miaoli County, Taiwan. .; Department of Health Services Administration, China Medical University, Taichung, Taiwan. .; Department of Family Medicine, Min-Sheng General Hospital, Taoyuan, Taiwan. .; National Center for Geriatrics and Welfare Research, National Health Research Institutes, Yunlin, Taiwan. .

Pokaż więcej

Źródło:

BMC medicine [BMC Med] 2024 Jan 04; Vol. 22 (1), pp. 8. Date of Electronic Publication: 2024 Jan 04.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Cardiovascular Diseases*
Humans ; Glucagon-Like Peptide-1 Receptor Agonists ; Cohort Studies ; Glucagon-Like Peptide 1 ; Liver ; Hypoglycemic Agents ; Retrospective Studies

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 42.

Tytuł:

Leptin and energy balance: exploring Leptin's role in the regulation of energy intake and energy expenditure.

Autorzy:

Tucker JAL; Department of Kinesiology and Physical Education, Wilfrid Laurier University, Waterloo, Canada.
Bornath DPD; Department of Kinesiology and Physical Education, Wilfrid Laurier University, Waterloo, Canada.
McCarthy SF; Department of Kinesiology and Physical Education, Wilfrid Laurier University, Waterloo, Canada.
Hazell TJ; Department of Kinesiology and Physical Education, Wilfrid Laurier University, Waterloo, Canada.

Pokaż więcej

Źródło:

Nutritional neuroscience [Nutr Neurosci] 2024 Jan; Vol. 27 (1), pp. 87-95. Date of Electronic Publication: 2022 Dec 30.

Typ publikacji:

Journal Article

MeSH Terms:

Ghrelin*/metabolism
Leptin*
Islet Amyloid Polypeptide/metabolism ; Islet Amyloid Polypeptide/pharmacology ; Appetite ; Energy Intake ; Glucagon-Like Peptide 1 ; Peptide YY ; Energy Metabolism ; Tyrosine/metabolism ; Tyrosine/pharmacology

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 43.

Tytuł:

Glucagon-Like Peptide-1 (GLP-1) during Ramadan: Narrative Review of the Published Literature.

Autorzy:

Alayed KM; Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Pokaż więcej

Źródło:

Journal of obesity [J Obes] 2023 Dec 26; Vol. 2023, pp. 8626081. Date of Electronic Publication: 2023 Dec 26 (Print Publication: 2023).

Typ publikacji:

Journal Article; Review

MeSH Terms:

Blood Glucose*
Hypoglycemia*
Humans ; Glucagon-Like Peptide 1 ; Fasting/adverse effects ; Fasting/physiology ; Islam

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 44.

Tytuł:

Drug Therapies for Diabetes.

Autorzy:

Weinberg Sibony R; Faculty of Medicine, Ben-Gurion University, Beer Sheva 8443944, Israel.
Segev O; Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Dor S; Faculty of Medicine, Ben-Gurion University, Beer Sheva 8443944, Israel.
Raz I; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112001, Israel.; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Jerusalem 91240, Israel.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2023 Dec 05; Vol. 24 (24). Date of Electronic Publication: 2023 Dec 05.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/chemically induced
Metformin*/therapeutic use
Humans ; Hypoglycemic Agents/pharmacology ; Quality of Life ; Blood Glucose ; Insulin/therapeutic use ; Insulin, Regular, Human/therapeutic use ; Glucagon-Like Peptide 1/therapeutic use ; Glucagon-Like Peptide-1 Receptor/agonists

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 45.

Tytuł:

Mendelian randomization analyses suggest a causal role for circulating GIP and IL-1RA levels in homeostatic model assessment-derived measures of β-cell function and insulin sensitivity in Africans without type 2 diabetes.

Autorzy:

Meeks KAC; Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, 12 South Drive Bldg 12A ste 1025, Bethesda, MD, 20892-5611, USA. .
Bentley AR; Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, 12 South Drive Bldg 12A ste 1025, Bethesda, MD, 20892-5611, USA.
Assimes TL; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; VA Palo Alto Healthcare System, Palo Alto, CA, USA.
Franceschini N; Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.
Adeyemo AA; Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, 12 South Drive Bldg 12A ste 1025, Bethesda, MD, 20892-5611, USA.
Rotimi CN; Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, 12 South Drive Bldg 12A ste 1025, Bethesda, MD, 20892-5611, USA.
Doumatey AP; Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, 12 South Drive Bldg 12A ste 1025, Bethesda, MD, 20892-5611, USA. .

Pokaż więcej

Źródło:

Genome medicine [Genome Med] 2023 Dec 04; Vol. 15 (1), pp. 108. Date of Electronic Publication: 2023 Dec 04.

Typ publikacji:

Journal Article

MeSH Terms:

Diabetes Mellitus, Type 2*/complications
Insulin Resistance*/genetics
Interleukin 1 Receptor Antagonist Protein*/genetics
Gastric Inhibitory Polypeptide*/genetics
Humans ; African People ; Blood Glucose ; Complement Factor D/genetics ; Genome-Wide Association Study ; Ghana ; Glucagon-Like Peptide 1 ; Insulin/genetics ; Interleukin-6/genetics ; Kenya ; Mendelian Randomization Analysis ; Risk Factors ; Nigeria

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 46.

Tytuł:

Incretin hormone responses to carbohydrate and protein/fat are preserved in adults with sulfonylurea-treated KCNJ11 neonatal diabetes.

Autorzy:

Bowman P; University of Exeter Medical School, Exeter, UK.; Exeter NIHR Clinical Research Facility, Exeter, UK.; NIHR Exeter Biomedical Research Centre (BRC), Exeter, UK.; Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.
Patel KA; University of Exeter Medical School, Exeter, UK.; Exeter NIHR Clinical Research Facility, Exeter, UK.; NIHR Exeter Biomedical Research Centre (BRC), Exeter, UK.; Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.
McDonald TJ; University of Exeter Medical School, Exeter, UK.; Exeter NIHR Clinical Research Facility, Exeter, UK.; NIHR Exeter Biomedical Research Centre (BRC), Exeter, UK.; Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.
Holst JJ; Faculty of Health and Medical Sciences, University of Copenhagen, Kobenhavn, Denmark.
Hartmann B; Faculty of Health and Medical Sciences, University of Copenhagen, Kobenhavn, Denmark.
Leveridge M; Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.
Shields BM; University of Exeter Medical School, Exeter, UK.; Exeter NIHR Clinical Research Facility, Exeter, UK.; NIHR Exeter Biomedical Research Centre (BRC), Exeter, UK.
Hammersley S; University of Exeter Medical School, Exeter, UK.; Exeter NIHR Clinical Research Facility, Exeter, UK.; Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.
Spaull SR; University of Exeter Medical School, Exeter, UK.; Exeter NIHR Clinical Research Facility, Exeter, UK.; Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.
Knight BA; University of Exeter Medical School, Exeter, UK.; Exeter NIHR Clinical Research Facility, Exeter, UK.; NIHR Exeter Biomedical Research Centre (BRC), Exeter, UK.; Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.
Flanagan SE; University of Exeter Medical School, Exeter, UK.; Exeter NIHR Clinical Research Facility, Exeter, UK.; NIHR Exeter Biomedical Research Centre (BRC), Exeter, UK.
Shepherd MH; University of Exeter Medical School, Exeter, UK.; Exeter NIHR Clinical Research Facility, Exeter, UK.; NIHR Exeter Biomedical Research Centre (BRC), Exeter, UK.; Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.
Andrews RC; University of Exeter Medical School, Exeter, UK.; Exeter NIHR Clinical Research Facility, Exeter, UK.; NIHR Exeter Biomedical Research Centre (BRC), Exeter, UK.
Hattersley AT; University of Exeter Medical School, Exeter, UK.; Exeter NIHR Clinical Research Facility, Exeter, UK.; NIHR Exeter Biomedical Research Centre (BRC), Exeter, UK.; Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.

Pokaż więcej

Źródło:

Journal of diabetes investigation [J Diabetes Investig] 2023 Dec; Vol. 14 (12), pp. 1378-1382. Date of Electronic Publication: 2023 Aug 21.

Typ publikacji:

Journal Article

MeSH Terms:

Diabetes Mellitus*
Diabetes Mellitus, Type 2*/metabolism
Infant, Newborn ; Adult ; Humans ; Incretins/therapeutic use ; Glucagon/metabolism ; Insulin/metabolism ; Blood Glucose/metabolism ; Gastric Inhibitory Polypeptide ; Glucagon-Like Peptide 1

SCR Disease Name:

Diabetes Mellitus, Permanent Neonatal

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 47.

Tytuł:

Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity.

Autorzy:

Quddos F; Fralin Biomedical Research Institute at VTC, Virginia Tech, Roanoke, VA, USA.; Graduate Program in Translational Biology, Medicine, and Health, Blacksburg, VA, USA.
Hubshman Z; Fralin Biomedical Research Institute at VTC, Virginia Tech, Roanoke, VA, USA.; Virginia Polytechnic Institute and State University, Blacksburg, VA, USA.
Tegge A; Fralin Biomedical Research Institute at VTC, Virginia Tech, Roanoke, VA, USA.
Sane D; Fralin Biomedical Research Institute at VTC, Virginia Tech, Roanoke, VA, USA.; Virginia Polytechnic Institute and State University, Blacksburg, VA, USA.
Marti E; Fralin Biomedical Research Institute at VTC, Virginia Tech, Roanoke, VA, USA.
Kablinger AS; Virginia Tech Carilion School of Medicine, Roanoke, VA, USA.
Gatchalian KM; Fralin Biomedical Research Institute at VTC, Virginia Tech, Roanoke, VA, USA.
Kelly AL; Fralin Biomedical Research Institute at VTC, Virginia Tech, Roanoke, VA, USA.; Graduate Program in Translational Biology, Medicine, and Health, Blacksburg, VA, USA.
DiFeliceantonio AG; Fralin Biomedical Research Institute at VTC, Virginia Tech, Roanoke, VA, USA.
Bickel WK; Fralin Biomedical Research Institute at VTC, Virginia Tech, Roanoke, VA, USA. .

Pokaż więcej

Źródło:

Scientific reports [Sci Rep] 2023 Nov 28; Vol. 13 (1), pp. 20998. Date of Electronic Publication: 2023 Nov 28.

Typ publikacji:

Journal Article

MeSH Terms:

Alcoholism*/complications
Alcoholism*/drug therapy
Diabetes Mellitus, Type 2*/drug therapy
Animals ; Humans ; Alcohol Drinking/drug therapy ; Gastric Inhibitory Polypeptide ; Glucagon-Like Peptide 1 ; Obesity/complications ; Obesity/drug therapy ; Ethanol ; Weight Loss ; Glucagon-Like Peptide-1 Receptor ; Hypoglycemic Agents

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 48.

Tytuł:

Once-weekly glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitors: cardiovascular effects in people with diabetes and cardiovascular disease.

Autorzy:

Tan X; Novo Nordisk Inc., Plainsboro, NJ, USA.
Liang Y; Novo Nordisk Inc., Plainsboro, NJ, USA.
Rajpura JR; Novo Nordisk Inc., Plainsboro, NJ, USA.
Yedigarova L; Novo Nordisk Inc., Plainsboro, NJ, USA.
Noone J; Novo Nordisk Inc., Plainsboro, NJ, USA.
Xie L; Novo Nordisk Inc., Plainsboro, NJ, USA.
Inzucchi S; Department of Endocrinology, Yale University, New Haven, CT, USA.
de Havenon A; Department of Neurology, Center for Brain and Mind Health, Yale School of Medicine, Yale University, 15 York St, New Haven, CT, 06510, USA. .

Pokaż więcej

Źródło:

Cardiovascular diabetology [Cardiovasc Diabetol] 2023 Nov 20; Vol. 22 (1), pp. 319. Date of Electronic Publication: 2023 Nov 20.

Typ publikacji:

Observational Study; Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Dipeptidyl-Peptidase IV Inhibitors*/adverse effects
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Cardiovascular Diseases*/diagnosis
Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/prevention & control
Myocardial Infarction*/diagnosis
Myocardial Infarction*/epidemiology
Myocardial Infarction*/complications
Ischemic Stroke*
Adult ; Humans ; Glucagon-Like Peptide-1 Receptor/agonists ; Risk Factors ; Glucagon-Like Peptide 1/therapeutic use ; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/therapeutic use ; Hypoglycemic Agents/adverse effects

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 49.

Tytuł:

Increased Insulin Secretion and Glucose Effectiveness in Obese Patients with Type 2 Diabetes following Bariatric Surgery.

Autorzy:

Visentin R; Department of Information Engineering, University of Padova, Padova, Italy.
Brodersen K; Department of Surgery, Viborg General Hospital, Denmark.
Richelsen B; Steno Diabetes Center Aarhus, Aarhus University Hospital & Clinical Medicine, Aarhus University, Denmark.
Møller N; Steno Diabetes Center Aarhus, Aarhus University Hospital & Clinical Medicine, Aarhus University, Denmark.
Dalla Man C; Department of Information Engineering, University of Padova, Padova, Italy.
Pedersen AK; Department of Clinical Research, University Hospital of Southern Denmark, Denmark.
Abrahamsen J; Department of Radiology, Viborg General Hospital, Denmark.
Holst JJ; Novo Nordisk Foundation, Center of Basic Metabolic Research and Department of Biomedical Sciences, The Panum Institute, University of Copenhagen, Denmark.
Nielsen MF; Department of Surgery, University Hospital of Southern Denmark, Denmark.

Pokaż więcej

Źródło:

Journal of diabetes research [J Diabetes Res] 2023 Nov 14; Vol. 2023, pp. 7127426. Date of Electronic Publication: 2023 Nov 14 (Print Publication: 2023).

Typ publikacji:

Journal Article

MeSH Terms:

Insulin Resistance*/physiology
Diabetes Mellitus, Type 2*
Bariatric Surgery*
Gastric Bypass*/methods
Humans ; Glucose/metabolism ; Insulin Secretion ; Blood Glucose/metabolism ; Obesity/complications ; Obesity/surgery ; Obesity/metabolism ; Insulin ; Glucagon-Like Peptide 1 ; Gastrectomy/methods

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 50.

Tytuł:

Anti-Incretin Gut Features Induced by Feed Supplementation with Alpha-Amylase: Studies on EPI Pigs.

Autorzy:

Pierzynowska K; Department of Biology, Lund University, 223 62 Lund, Sweden.; Department of Animal Physiology, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, 05-110 Jabłonna, Poland.; Anara AB, 231 32 Trelleborg, Sweden.
Wychowański P; Anara AB, 231 32 Trelleborg, Sweden.; Department of Head and Neck and Sensory Organs, Division of Oral Surgery and Implantology, Institute of Clinical Dentistry, Gemelli Foundation for the University Policlinic, Catholic University of the 'Sacred Heart', 00168 Rome, Italy.; Department of Oral Surgery, Medical University of Gdańsk, 80-211 Gdańsk, Poland.; Specialized Private Implantology Clinic Wychowanski Stomatologia, 02-517 Warsaw, Poland.
Zaworski K; Department of Animal Physiology, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, 05-110 Jabłonna, Poland.
Woliński J; Department of Animal Physiology, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, 05-110 Jabłonna, Poland.; Large Animal Models Laboratory, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, 05-110 Jabłonna, Poland.
Donaldson J; Anara AB, 231 32 Trelleborg, Sweden.; School of Physiology, Faculty of Health Sciences, University of the Witwatersrand (WITS), Johannesburg 2050, South Africa.
Pierzynowski S; Department of Biology, Lund University, 223 62 Lund, Sweden.; Anara AB, 231 32 Trelleborg, Sweden.; Department of Medical Biology, Institute of Rural Health, 20-090 Lublin, Poland.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2023 Nov 10; Vol. 24 (22). Date of Electronic Publication: 2023 Nov 10.

Typ publikacji:

Journal Article

MeSH Terms:

Incretins*
Blood Glucose*
Animals ; Swine ; alpha-Amylases ; Pancrelipase ; Insulin ; Glucagon-Like Peptide 1 ; Amylases ; Dietary Supplements ; Gastric Inhibitory Polypeptide

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły